Dr. Amitava Banerjee: key facts
- Kind of voice
- Clinician
- Role
- Professor in clinical data science at UCL and honorary consultant cardiologist at University College London Hospitals and Barts Health NHS Trusts
- Quoted on
- Respiratory (asthma/COPD), Long Covid
- Press citations held
- 2
- Most recently quoted
- 10 Sept 2026
- First quoted
- 6 Aug 2026
“the medicines were chosen based on the most promising theories of how to improve long Covid when the research began in 2021”
What Dr. Amitava Banerjee has said
“Lead author Dr. Amitava Banerjee of University College London in London, U.K., and colleagues investigated whether pre-clinic MRI could identify organ impairment early enough to guide care.”
Professor in clinical data science at UCL and honorary consultant cardiologist at University College London Hospitals and Barts Health NHS Trusts · Long Covid · 6 Aug 2026 · Multi-organ MRI shows no added benefit in major UK Long COVID trial ↗
Where Dr. Amitava Banerjee has been quoted
- Commonly-used drugs show small benefit for long-Covid fatiguepulsetoday.co.uk · 10 Sept 2026
- Multi-organ MRI shows no added benefit in major UK Long COVID trialauntminnieeurope.com · 6 Aug 2026
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 10 Sept 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.